Glenn N. Levine MD, FAHA, FACCMaster Clinician and Professor of Medicine, Baylor College of Medicine; Chief, Cardiology Section, Michael E. DeBakey VA Medical Center, Houston, Texas
Dr. Glenn N. Levine is Master Clinician and Professor of Medicine at Baylor College of Medicine, and Chief of Cardiology Section at the Michael E. DeBakey VA Medical Center, both in Houston, Texas. Dr. Levine is recognized locally, regionally, nationally and internationally for his teaching, lecturing, and educational abilities, and for his expertise in cardiovascular disease, including acute coronary syndromes (heart attack), antiplatelet therapy, acute and critical cardiac care, coronary revascularization (stenting) and guidelines on cardiovascular care.
Dr. Levine is the recipient of 6 Baylor College of Medicine Fulbright & Jaworski, and Norton Rose Fulbright, faculty excellence awards, including those in teaching, educational leadership, and enduring educational materials. He was awarded the prestigious Baylor College of Medicine Master Clinician Lifetime Award, recognizing his clinical skills and abilities to educate others on the management of patients with cardiovascular disease, as well as the Baylor College of Medicine’s Presidential Award for Excellence in Education, the college’s highest such honor. Dr. Levine’s clinical and educational leadership have also been recognized by the American Heart Association, who awarded him their Distinguished Achievement Award, and by the American College of Cardiology, who awarded him the prestigious Gifted Educator Award, a national award bestowed upon only one cardiologist each year.
Dr. Levine has authored or edited a total of 15 educational textbooks and handbooks, including a 1000+ page textbook and atlas on cardiovascular disease. Several of these books have additionally been published internationally in different languages, including Russian, Lithuanian, Vietnamese, and Spanish. He has led and first-authored seven American Heart Association Scientific Statements. He served as chair of the writing group of the 2011 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on PCI, chair of the 2016 ACC/AHA Guideline Focused Update on Duration of DAPT (when and how long to treat patients with cardiovascular disease with antiplatelet therapies), and co-chair of the 2015 ACC/AHA/SCAI Guideline Focused Update on Primary PCI (treating patients with STEMI), as well as serving as a writing group member on several other guidelines. Recently, Dr. Levine served as chair of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, leading and supervising all of the nation’s cardiovascular guidelines.
More recently, Dr. Levine’s focuses have been on the more global relationship of the heart and mind, how psychological health affects the heart, well-being, meditation and mindfulness.
Socially, Dr. Levine is a passionate advocate of animal rescue and adoption, and the humane treatment of animals, belonging to over a dozen such advocate and animal rescue organizations (in addition to having 3 rescue dogs himself), and practices a balanced approach to life, including meditation and mindfulness.
DisclosuresDr. Levine has no relevant disclosures.
Recent Contributions to PracticeUpdate:
- Optimal Timing for Starting DOACs After Ischemic Stroke With Atrial Fibrillation
- Aspirin vs Clopidogrel for Chronic Maintenance Monotherapy After PCI
- Early Aspirin Discontinuation After Coronary Stenting
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
- Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery
- Risk Associated With Surgery Within 12 Months After Coronary DES Implantation
- Early Cessation of Adenosine Receptor Inhibitors Increases Risk for MACE